Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 1601 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  Haemonetics Corporation

Hospital Furniture Market size is set to grow by USD 7.83 billion from 2023-2027, Rise in international accreditation by hospitals boost the market, Technavio

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

Premier Dermatology Partners Opens New Location in Fort Lauderdale

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

Gastroparesis Market to Witness Upsurge in Growth at a CAGR of 7% by 2034 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as President of Research & Development

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Oculis Holding AG

Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Medicenna Therapeutics Corp.

BYG4lab®, Innovator of Next Generation Software Suites for Laboratories and Diagnostics, Appoints Tim Bickley as VP Sales US to Spearhead Entry into US market

Read more ››
By: GlobeNewswire - 10 Apr 2024

Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first ‘2 in 1’ immune cell engager CB699 at AACR 2024

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Crescendo Biologics Ltd

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions 

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  MoonLake Immunotherapeutics AG

Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Apollomics, Inc.

BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  BioXcel Therapeutics, Inc.

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  IGM Biosciences, Inc.

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Axsome Therapeutics, Inc.

AAMI Announces Ralph Basile Appointed to Philanthropic Activities for the AAMI Foundation

Read more ››
By: GlobeNewswire - 10 Apr 2024

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Nurix Therapeutics, Inc.

Spectral Medical Provides Tigris Trial Update

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Spectral Medical Inc.

Interactive Strength Inc. (Nasdaq: TRNR) to Exhibit CLMBR at FIBO Global Fitness, the World's Largest Trade Show for Fitness, Wellness and Health on April 11-14

Read more ››
By: GlobeNewswire - 10 Apr 2024

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Hookipa Pharma Inc.

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Ocugen, Inc.

Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders

Read more ››
By: GlobeNewswire - 10 Apr 2024
Related companies:  Clearmind Medicine Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑